Law360, New York (March 16, 2009, 12:00 AM ET) -- Pfizer Inc., Forest Laboratories Inc. and Warner-Lambert Co. have been hit with a proposed class action accusing them of coordinating a scheme to mask suicide risks associated with antidepressants Lexapro and Celexa in pediatric patients while simultaneously offering doctors kickbacks to prescribe the drugs for younger patients.
The New Mexico UFCW Union’s and Employers’ Health and Welfare Trust Fund filed the putative class action Thursday in the U.S. District Court for the Eastern District of New York, charging the drugmakers with a slew of claims, including...
Drug Cos. Hid SSRI Risks, Paid Docs Kickbacks: Suit
To view the full article, take a free trial now.
